Company intelligence / Profile preview

Medeorex

New York, NY, USA

Ownership: Private
Development stage: Other

Overview

Medeorex, Inc. was a New York-based health services holding company that operated in the mid-2000s. The company gained attention in the biotechnology sector through its attempted acquisition of CardioGenics, a firm specializing in proprietary in-vitro diagnostics and cardiac marker testing. Medeorex was closely affiliated with Inyx, Inc., a specialty pharmaceutical manufacturer, and shared key leadership including Dr. Jack Kachkar. Following a name change to Karver International, Inc. in 2005, the company eventually became inactive as its broader corporate network faced significant financial and legal challenges.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Protein Biomarker Diagnostics

Partnerships

Inyx, Inc.

Beyond the preview

Go deeper on Medeorex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medeorex.

Explore the full profile